Loading clinical trials...
Loading clinical trials...
To measure the level of drug in nasal tissue and blood after taking a single 2g dose or 500mg tablets for up to 3 days.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis
NCT06914908 · Chronic Rhinosinusitis With Nasal Polyps
NCT05246267 · Chronic Rhinosinusitis With Nasal Polyps
NCT07340411 · Chronic Rhinosinusitis, Postoperative Care
NCT07125586 · Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Pfizer Investigational Site
Alabaster, Alabama
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions